Which CT perfusion parameter best reflects cerebrovascular reserve?: Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients

American Journal of Neuroradiology

Volumn 29, Issue 9, 2008, Pages 1658-1663

  Rim, N J ^a   Kim, Ho Sung ^a   Shin, Y S ^a   Kim, S Y ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CYSTEINE ETHYL ESTER TC 99M; IOHEXOL;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN PERFUSION; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; MOYAMOYA DISEASE; PARAMETER; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACETAZOLAMIDE; ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD VOLUME; CARBONIC ANHYDRASE INHIBITORS; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; CYSTEINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MOYAMOYA DISEASE; ORGANOTECHNETIUM COMPOUNDS; PERFUSION IMAGING; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 54249092982     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1229     Document Type: Article

References (24)

1. Endo H, Inoue T, Ogasawara K, et al. Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography. Stroke 2006;37:388-92
2. Kuroda S, Houkin K, Kamiyama H, et al. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110-16
3. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857-62
4. Schroeder T. Cerebrovascular reactivity to acetazolamide in carotid artery disease: enhancement of side-to-side CBF asymmetry indicates critically reduced perfusion pressure. Neurol Res 1986;8:231-36
5. Yamamoto S, Watanabe M, Uematsu T, et al. Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol 2004;25:242-47
6. Chen A, Shyr MH, Chen TY, et al. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. AJNR Am J Neuroradiol 2006;27:1876-81
7. Eastwood JD, Alexander MJ, Petrella JR, et al. Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. AJNR Am J Neuroradiol 2002;23:285-87
8. Kaneko K, Kuwabara Y, Mihara F, et al. Validation of the CBF, CBV, and MTT values by perfusion MRI in chronic occlusive cerebrovascular disease: a comparison with 15O-PET. Acad Radiol 2004;11:489-97
9. Lythgoe DJ, Ostergaard L, William SC, et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 2000;18:1-11
10. Suzuki J, Kodama N. Moyamoya disease: a review. Stroke 1983;14:104-10
11. Wintermark M, Maeder P, Thiran JP, et al. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 2001;11:1220-30
12. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol 1983;8:94-99
13. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol 2001;22:928-36
14. Van der Zwan A, Hillen B, Tulleken CAF, et al. Variability of the territories of the major cerebral arteries. J Neurosurg 1992;77:927-40
15. Hupperts RMM, Lodder J, Heuts-van Raak, et al. Borderzone brain infarcts on CT taking into account the variability in vascular supply areas. Cerebrovasc Dis 1996;6:294-300
16. 133Xe SPECT in occlusive cerebrovascular disease. Am J Roentgenol 2002;179:229-35
17. Yamauchi H, Okazawa H, Sugimoto K, et al. The effect of deafferentation on cerebral blood flow response to acetazolamide. AJNR Am J Neuroradiol 2004;25:92-96
18. Nariai T, Suzuki R, Hirakawa K, et al. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron-emission tomography. AJNR Am J Neuroradiol 1995;16:563-70
19. Yamauchi H, Okazawa H, Kishibe Y, et al. Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease. Eur J Nucl Med 2002;29:1349-56
20. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999;53:251-59
21. Webster MW, Makaroun MS, Steed DL, et al. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995;21:338-45
22. Calamante F, Ganesan V, Kirkham FJ, et al. MR perfusion imaging in Moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 2001;32:2810-16
23. Togao O, Mihara F, Yoshiura T, et al. Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. AJNR Am J Neuroradiol 2006;27:391-97
24. Calamante F, Mørup M, Hansen LK. Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med 2004;52:789-97